Authors:
Daly, CD
Campbell, MK
MacLeod, AM
Cody, DJ
Vale, LD
Grant, AM
Donaldson, C
Wallace, SA
Lawrence, PD
Khan, IH
Citation: Cd. Daly et al., Do the Y-set and double-bag systems reduce the incidence of CAPD peritonitis? A systematic review of randomized controlled trails, NEPH DIAL T, 16(2), 2001, pp. 341-347
Authors:
Rowley, M
Hallett, DJ
Goodacre, S
Moyes, C
Crawforth, J
Sparey, TJ
Patel, S
Marwood, R
Patel, S
Thomas, S
Hitzel, L
O'Connor, D
Szeto, N
Castro, JL
Hutson, PH
MacLeod, AM
Citation: M. Rowley et al., 3-(4-fluoropiperidin-3-yl)-2-phenylindoles as high affinity, selective, and orally bioavailable h5-HT2A receptor antagonist, J MED CHEM, 44(10), 2001, pp. 1603-1614
Authors:
Elliott, RJ
Bennet, AJ
Braun, CA
MacLeod, AM
Borgford, TJ
Citation: Rj. Elliott et al., Active-site variants of Streptomyces griseus protease B with peptide-ligation activity, CHEM BIOL, 7(3), 2000, pp. 163-171
Authors:
MacLeod, AM
Yan, X
Gillespie, WA
Knippels, GMH
Oepts, D
van der Meer, AFG
Rella, CW
Smith, TJ
Schwettman, HA
Citation: Am. Macleod et al., Formation of low time-bandwidth product, single-sided exponential optical pulses in free-electron laser oscillators, PHYS REV E, 62(3), 2000, pp. 4216-4220
Authors:
Ramsay, CR
Campbell, MK
Cantarovich, D
Catto, G
Cody, J
Daly, C
Delcroix, C
Edward, N
Grimshaw, JM
van Hamersvelt, HW
Henderson, IS
Khan, IH
Koene, RAP
Papadimitrou, M
Ritz, E
Tsakiris, D
MacLeod, AM
Citation: Cr. Ramsay et al., Evaluation of clinical guidelines for the management of end-stage renal disease in Europe: the EU BIOMED 1 Study, NEPH DIAL T, 15(9), 2000, pp. 1394-1398
Authors:
Campbell, MK
Daly, C
Wallace, SA
Cody, DJ
Donaldson, C
Grant, AM
Khan, IH
Lawrence, P
Vale, L
MacLeod, AM
Citation: Mk. Campbell et al., Evidence-based medicine in nephrology: identifying and critically appraising the literature, NEPH DIAL T, 15(12), 2000, pp. 1950-1955
Authors:
Lewis, RT
Ladduwahetty, T
Merchant, KJ
Keown, LE
Hitzel, L
Verrier, H
Stevenson, GI
MacLeod, AM
Citation: Rt. Lewis et al., An efficient protocol for the preparation of primary alcohols bearing a beta-chiral center via an oxazolidinone auxiliary mediated resolution, and application to the synthesis of 4,4-disubstituted piperidine substance P antagonists, J ORG CHEM, 65(8), 2000, pp. 2615-2618
Authors:
Metcalfe, W
MacLeod, AM
Bennett, D
Simpson, K
Khan, IH
Citation: W. Metcalfe et al., Equity of renal replacement therapy utilization: a prospective population-based study, QJM-MON J A, 92(11), 1999, pp. 637-642
Authors:
Bourrain, S
Neduvelil, JG
Beer, MS
Stanton, JA
Showell, GA
MacLeod, AM
Citation: S. Bourrain et al., 4-hydroxy-1-[3-(5-(1,2,4-triazol-4-yl)-1H-indol-3-yl)propyl]piperidines: Selective h5-HT1D agonists for the treatment of migraine., BIOORG MED, 9(23), 1999, pp. 3369-3374
Authors:
van Niel, MB
Beer, MS
Castro, JL
Cheng, SKF
Evans, DC
Heald, A
Hitzel, L
Hunt, P
Mortishire-Smith, R
O'Connor, D
Watt, AP
MacLeod, AM
Citation: Mb. Van Niel et al., Parallel synthesis of 3-aryloxy-2-propanolamines and evaluation as dual affinity 5-HT1A and 5-HT re-uptake ligands, BIOORG MED, 9(22), 1999, pp. 3243-3248
Authors:
Caskey, FJ
Metcalfe, W
MacLeod, AM
Khan, IH
Citation: Fj. Caskey et al., Is there a rationale for rationing chronic dialysis? Question is difficultto address on basis of retrospective studies, BR MED J, 318(7198), 1999, pp. 1619-1620
Authors:
Feiwell, RJ
Black, KJ
McGee-Minnich, LA
Snyder, AZ
MacLeod, AM
Perlmutter, JS
Citation: Rj. Feiwell et al., Diminished regional cerebral blood flow response to vibration in patients with blepharospasm, NEUROLOGY, 52(2), 1999, pp. 291-297
Authors:
Chambers, MS
Street, LJ
Goodacre, S
Hobbs, SC
Hunt, P
Jelley, RA
Matassa, VG
Reeve, AJ
Sternfeld, F
Beer, MS
Stanton, JA
Rathbone, D
Watt, AP
MacLeod, AM
Citation: Ms. Chambers et al., 3-(piperazinylpropyl)indoles: Selective, orally bioavailable h5-HT1D receptor agonists as potential antimigraine agents, J MED CHEM, 42(4), 1999, pp. 691-705
Authors:
van Niel, MB
Collins, I
Beer, MS
Broughton, HB
Cheng, SKF
Goodacre, SC
Heald, A
Locker, KL
MacLeod, AM
Morrison, D
Moyes, CR
O'Connor, D
Pike, A
Rowley, M
Russell, MGN
Moyes, CR
O'Connor, D
Pike, A
Rowley, M
Russell, MGN
Sohal, B
Stanton, JA
Thomas, S
Verrier, H
Watt, AP
Castro, JL
Citation: Mb. Van Niel et al., Fluorination of 3-(3-(piperidin-1-yl)propyl)indoles and 3-(3-(piperazin-1-yl)propyl)indoles gives selective human 5-HT1D receptor ligands with improved pharmacokinetic profiles, J MED CHEM, 42(12), 1999, pp. 2087-2104